(0233–0279) Miscellaneous Rheumatic & Inflammatory Diseases Poster I

Sunday, October 26, 2025

10:30 AM - 12:30 PM Central Time

Location: Hall F1

CE: 0.00

Presentations:

10:30 AM - 12:30 PM Central Time

A Multicenter Retrospective Case Series of Patients with Susac Syndrome Treated with Rituximab
Abstract Poster Presenter: Michelle Benjamin, MD – Stanford Health Care
10:30 AM - 12:30 PM Central Time

A Phase 1, Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Ascending Doses and Food Effects of BGB-45035, a Chimeric Degradation Activating Compound (CDAC), in Healthy Participants
Abstract Poster Presenter: Vaibhav Mundra, MD – BeOne Medicines USA, Inc.
10:30 AM - 12:30 PM Central Time

A Snapshot of Subcutaneous Infliximab Use in Inflammatory Rheumatic Diseases: A Multicenter Italian Study
Abstract Poster Presenter: Stefano Gentileschi, MD – University Of Siena
10:30 AM - 12:30 PM Central Time

Assessment of Baseline igg4-rd Disease Characteristics and Impact upon Safety and Efficacy of Inebilizumab: Results from the MITIGATE Study
Abstract Poster Presenter: Yoshiya Tanaka, MD, PhD – University of Occupational and Environmental Health, Japan
10:30 AM - 12:30 PM Central Time

Autoinflammatory diseases in adult patients. Spanish registry.
Abstract Poster Presenter: Eztizen Labrador-Sánchez, MD – Hospital Universitario San Pedro
10:30 AM - 12:30 PM Central Time

Behçet’s Disease in a Diverse Urban Single-Center Cohort in the United States: HLA-B Alleles and Clinical Features
Abstract Poster Presenter: Amir Razmjou, MD, MSc – UCLA / GLA-VA
10:30 AM - 12:30 PM Central Time

Capillaroscopic Signatures in Autoimmune Rheumatic Diseases: Unveiling Patterns in Systemic Sclerosis, Polyautoimmunity, and PAH
Abstract Poster Presenter: Jairo Cajamarca, MD (he/him/his) – Fundacion universitaria de ciencia de la Salud
10:30 AM - 12:30 PM Central Time

Chronic PPI Use Association with Development of Autoimmune Conditions: Retrospective Cohort Study
Abstract Poster Presenter: Nanuka Tsibadze, MD – Jefferson Health - Einstein
10:30 AM - 12:30 PM Central Time

Classic and Clinically Amyopathic Dermatomyositis: Autoantibody Positivity
Abstract Poster Presenter: Xiwei Yang, BA – Perelman School of Medicine, University of Pennsylvania
10:30 AM - 12:30 PM Central Time

Clearing the Smoke: Association Between Cannabis Use and Autoimmune Disease Incidence in a Retrospective Cohort Analysis
Abstract Poster Presenter: Justin Riley Lam, MD – Jefferson Einstein Hospital
10:30 AM - 12:30 PM Central Time

Clinical and serological characteristics of anti-Ku autoantibodies in a Hispanic cohort
Abstract Poster Presenter: Emmanuel Dominguez-Chapa, MS (he/him/his) – Universidad Autonoma de Nuevo Leon
10:30 AM - 12:30 PM Central Time

Clinical Landscape and Severity Markers of VEXAS Syndrome in a Spanish Cohort: Findings from VEXASSER Study Group
Abstract Poster Presenter: Paula García-Escudero, MD – Hospital Universitario Álava
10:30 AM - 12:30 PM Central Time

Clinical Presentation of Igg4-Related Disease. Multicenter Study and Literature Review
Abstract Poster Presenter: Rafael Gálvez Sánchez, Sr, MD – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
10:30 AM - 12:30 PM Central Time

Comparative Outcomes in MAGIC Syndrome versus Relapsing Polychondritis Alone: A Propensity-Matched Analysis
Abstract Poster Presenter: Justin Riley Lam, MD – Jefferson Einstein Hospital
10:30 AM - 12:30 PM Central Time

Contemporary Recurrent Pericarditis Management – Real-world Evidence of Limited Cardiac Magnetic Resonance Imaging Prior to Initiating Rilonacept
Abstract Poster Presenter: Brittany Weber, MD, PhD – Brigham and Women's Hospital
10:30 AM - 12:30 PM Central Time

Development of a Consensus Definition of VEXAS Flare for Use in Clinical Research
Abstract Poster Presenter: Lachelle Weeks, MD, PhD – Dana-Farber Cancer Institute
10:30 AM - 12:30 PM Central Time

Diagnostic Challenge of IgG4-related Disease: Comparison Between ACR/EULAR, Umehara, and Okazaki Criteria
Abstract Poster Presenter: Rafael Gálvez Sánchez, Sr, MD – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
10:30 AM - 12:30 PM Central Time

Effectiveness and safety of Anifrolumab in Non-Systemic Cutaneous Lupus
Abstract Poster Presenter: Carmen Lasa Teja, n/a – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
10:30 AM - 12:30 PM Central Time

Effector CD8+ T cells and PD-1hi CXCL13hi CD4+ T cells contribute to recurrent immune checkpoint inhibitor mediated inflammatory arthritis
Abstract Poster Presenter: Sang Kim, MD – Yale University
10:30 AM - 12:30 PM Central Time

Efficacy and Safety of JAK Inhibitors in Behçet's Syndrome: A Systematic Literature Review
Abstract Poster Presenter: Bercemhan Sulu, MD (she/her/hers) – Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology
10:30 AM - 12:30 PM Central Time

Epidemiology of adult-onset Systemic Autoinflammatory Diseases in a well-defined population from northern spain
Abstract Poster Presenter: Carmen Lasa Teja, n/a – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
10:30 AM - 12:30 PM Central Time

Fracture Risk in Intestinal Autoimmune-mediated Diseases Patients: Clinical Insights from REMS
Abstract Poster Presenter: Edmund MacLaughlin, MD – Rheumatology Associates of Delmarva
10:30 AM - 12:30 PM Central Time

Impact of Mepolizumab on Idiopathic Hypereosinophilic Syndromes: Preliminary Analysis of a Monocentric Retrospective Cohort
Abstract Poster Presenter: Jacopo Mora, MD – ASST Spedali Civili di Brescia
10:30 AM - 12:30 PM Central Time

Influence of Menopausal Status on Coronary Artery Calcium Burden and Cardiovascular Computed Tomography Abnormalities in Inflammatory Arthritis
Abstract Poster Presenter: Mohammed Mohammed, MBChB (he/him/his) – University of Toronto
10:30 AM - 12:30 PM Central Time

Inhaled pirfenidone as an innovative therapeutic approach to treat autoimmune ILD and other forms of Progressive Pulmonary Fibrosis: Phase 2b Study Design
Abstract Poster Presenter: Kristin B. Highland, MD, MS – Cleveland Clinic
10:30 AM - 12:30 PM Central Time

Monogenic autoinflammatory diseases and undefined autoinflammatory syndrome in Western Mediterranean adults: clinical, genetic, and therapeutic insights
Abstract Poster Presenter: Alba Maria Torrat Noves, MD – Hospital Universitari i Politècnic La Fe de Valencia
10:30 AM - 12:30 PM Central Time

Multicenter study and literature review of JAK inhibitor treatment in refractory uveitis due to different immune-mediated inflammatory pathologies
Abstract Poster Presenter: Nuria Barroso Garcia, -None-, MD – Hospital Regional Universitario Málaga
10:30 AM - 12:30 PM Central Time

Obesity as a possible confusion factor in the scleroderma pattern
Abstract Poster Presenter: Eva Álvarez Andrés, PhD (she/her/hers) – Hospital Severo Ochoa ( Madrid)
10:30 AM - 12:30 PM Central Time

Ocular Involvement in Behçet’s Disease: Comparative Study of Two Classification Criteria in Clinical Practice
Abstract Poster Presenter: Rafael Gálvez Sánchez, Sr, MD – Division of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain.
10:30 AM - 12:30 PM Central Time

Ophthalmology Screening for Asymptomatic Uveitis in Sarcoidosis Patients: A Single-Center Investigation
Abstract Poster Presenter: Justin Nguyen, MD – Virginia Commonwealth University Health Systems
10:30 AM - 12:30 PM Central Time

Performance characteristics of anti-Collagen II antibodies for diagnosing inflammatory and non-inflammatory diseases: a systematic review and meta-analysis
Abstract Poster Presenter: Karyssa Stonick, BS – National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH)
10:30 AM - 12:30 PM Central Time

Pharmacosurvellience study of FDA Adverse Event Reporting System (FAERS) events of Secukinumab and Guselkumab
Abstract Poster Presenter: Nur Barlas, MD – Tulane University
10:30 AM - 12:30 PM Central Time

Plasma Proteomic Profiling Identifies Inflammatory Proteins and Pathways Associated With Non-idiopathic and Idiopathic Retroperitoneal Fibrosis
Abstract Poster Presenter: Thomas Pelowitz, BS – Mayo Clinic
10:30 AM - 12:30 PM Central Time

Preclinical Characterization of ABB071 – a Humanized anti-CD180 Antibody that Modulates Multiple Pro-inflammatory Immune Pathways for the Treatment of Autoimmune and Inflammatory Disorders
Abstract Poster Presenter: Margaret McDaniel, PhD – Abacus Bioscience
10:30 AM - 12:30 PM Central Time

Predictors of Arterial Stiffness in Connective Tissue Diseases: Insights from the Lupus Extended Autoimmune Phenotype (LEAP) Cohort Study
Abstract Poster Presenter: Cristiana Sieiro Santos, MD – Centre for Musculoskeletal Research, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
10:30 AM - 12:30 PM Central Time

Randomized Confirmatory Basket Trial: Performance Evaluation of a Simulated Application Example in Rare Disease Using Real World Data
Abstract Poster Presenter: Linchen He, PhD – Novartis
10:30 AM - 12:30 PM Central Time

Real-World Effectiveness of Mepolizumab on Gastrointestinal Involvement in Eosinophilic Granulomatosis with Polyangiitis and Hypereosinophilic Syndrome: A Multicenter Retrospective Study
Abstract Poster Presenter: Alessia Gatti, MD – University of Brescia
10:30 AM - 12:30 PM Central Time

Safety of Guselkumab in Inflammatory Bowel Disease Up to 1 Year: Integrated Safety Analysis of Phase 2 and 3 Studies in Crohn’s Disease and Ulcerative Colitis
Abstract Poster Presenter: Karissa Lozenski, PhD – Johnson & Johnson
10:30 AM - 12:30 PM Central Time

Safety of Rilzabrutinib, a BTK Inhibitor, in Adult Patients with IgG4-related disease (IgG4-RD) in a 52-week Phase 2 Open-label Study
Abstract Poster Presenter: Alireza Meysami – Henry Ford Health
10:30 AM - 12:30 PM Central Time

Seeing Beyond the Eye: Subclinical Audio-Vestibular Involvement in Vogt-Koyanagi-Harada Disease
Abstract Poster Presenter: Mohamed Tharwat Hegazy, MD, PhD, FACR (he/him/his) – Faculty of Medicine, Cairo University
10:30 AM - 12:30 PM Central Time

The Role of Extracorporeal Membrane Oxygenation in Cardiopulmonary Dysfunction Due to Rheumatologic Diseases: A Systematic Review
Abstract Poster Presenter: Kari Falaas, MD – University of Minnesota
10:30 AM - 12:30 PM Central Time

Transplant-free survival in patients with systemic autoimmune rheumatic diseases and progressive pulmonary fibrosis in the ILD-PRO Registry
Abstract Poster Presenter: Sonali Bracken, MD, PhD – Duke University Medical Center
10:30 AM - 12:30 PM Central Time

Use of Nintedanib in Patients with Progressive Pulmonary Fibrosis
Abstract Poster Presenter: Elizabeth Volkmann, MD, MS – University of California, Los Angeles
10:30 AM - 12:30 PM Central Time

Differential Effects of GLP-1 Receptor Agonists versus SGLT2 Inhibitors on Hypoglycemia and Infection Risk in Diabetic Patients with Inflammatory Arthritis
Abstract Poster Presenter: Gurjot Singh, MD – Trihealth Good Samaritan Hospital
10:30 AM - 12:30 PM Central Time

Use of Corneal Confocal Microscopy to Assess Small Fiber Neuropathy in Patients with Sarcoidosis
Abstract Poster Presenter: Huzaefah Syed, MD, MPH, FACR – Virginia Commonwealth University Medical Center
10:30 AM - 12:30 PM Central Time

Mortality Trends due to Hypertension Related Deaths in Elderly Patients with Inflammatory Polyarthropathy: A CDC WONDER Analysis of 21 Years
Abstract Poster Presenter: Rehan Ishaque, MBBS – Liaquat University of Medical Health & Sciences, Jamshoro
10:30 AM - 12:30 PM Central Time

Safety and Efficacy of T Cell Engager Therapy in patients with refractory Autoimmune Disease
Abstract Poster Presenter: Ricardo Grieshaber-Bouyer, MD, PhD – University Hospital Erlangen